Literature DB >> 18804744

Prevalence of different gadolinium enhancement patterns in patients after heart transplantation.

Henning Steen1, Constanze Merten, Sonja Refle, Roland Klingenberg, Thomas Dengler, Evangelos Giannitsis, Hugo A Katus.   

Abstract

OBJECTIVES: Transplant coronary artery disease (TCAD) limits long-term survival after heart transplantation (HTX). We hypothesized that contrast-enhanced magnetic resonance imaging (CE-MRI) detects chronic TCAD-related myocardial infarctions (MIs), even in patients with angiographically classified mild TCAD.
BACKGROUND: Coronary angiography underestimates the TCAD-degree, subsequently missing occluded small coronary arteries and resulting MI. CE-MRI as a noninvasive imaging technique identifies infarct-typical MI and myocardial fibrosis.
METHODS: CE-MRI (gadolinium: 0.2 mmol/kg/bw) was performed in 53 HTX patients on a 1.5-T MRI scanner (Philips, Best, the Netherlands). Infarct-typical CE-MRI areas were classified as: I=<or=25%, II=25% to 50%, III=50% to 75% and IV=>or=75%. Infarct-atypical forms were divided into diffuse, spotted, intramural, and infero-septal. Coronary angiography results were reviewed qualitatively with the TCAD score (TCAD I=mild evidence; II=30% to 75%, III=>or=75% stenosis). Groups were compared with analysis of variance (statistically significant p values<or=0.05).
RESULTS: Infarct-typical CE-MRI was already present in TCAD I+II, increased significantly between groups (I=23%, II=33%, III=84%, p<0.05), and involved only single coronary territories in TCAD I but multiple vessels in TCAD II+III. Infarct-atypical CE-MRI was equally distributed across all TCAD stages (I=50% vs. II=58% vs. III=42%, p=NS) without relation to a coronary territory. Patients with only infarct-atypical CE-MRI were associated with significantly better left ventricular function compared with patients with infarct-typical or combined CE-MRI patterns (ejection fraction=66+/-6% vs. 45+/-16% or 60+/-13%; end-diastolic volume=139+/-32 ml vs. 148+/-27 ml or 164+/-43 ml; end-systolic volume=47+/-15 ml vs. 81+/-27 ml or 69+/-38 ml, p<or=0.05).
CONCLUSIONS: CE-MRI allows identification of silent MI in apparently event-free HTX patients and is able to disclose myocardial fibrosis already in patients with absent or mild angiographic TCAD. CE-MRI might be helpful to establish an earlier TCAD diagnosis and to intensify medical treatment. Future studies are necessary to test prognostic implications associated with CE-MRI patterns.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18804744     DOI: 10.1016/j.jacc.2008.05.059

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  19 in total

1.  Cardiac allograft vasculopathy : complications and imaging studies.

Authors:  G Di Bella; F Minutoli; S Coglitore; A Recupero; R Donato; R Caruso; P Grimaldi; S Lentini
Journal:  Herz       Date:  2011-10       Impact factor: 1.443

Review 2.  Transplant allograft vasculopathy: Role of multimodality imaging in surveillance and diagnosis.

Authors:  Gregory A Payne; Fadi G Hage; Deepak Acharya
Journal:  J Nucl Cardiol       Date:  2015-12-28       Impact factor: 5.952

3.  Myocardial Fibrosis and Prognosis in Heart Transplant Recipients.

Authors:  Andrew Hughes; Osama Okasha; Afshin Farzaneh-Far; Felipe Kazmirczak; Prabhjot S Nijjar; Pratik Velangi; Mehmet Akçakaya; Cindy M Martin; Chetan Shenoy
Journal:  Circ Cardiovasc Imaging       Date:  2019-10-15       Impact factor: 7.792

4.  Prevalence of different forms of infarct-atypical late gadolinium enhancement in patients early and late after heart transplantation.

Authors:  M F Braggion-Santos; F Andre; D Lossnitzer; E Hofmann; J Simpfendörfer; A Dösch; H A Katus; H Steen
Journal:  Clin Res Cardiol       Date:  2014-01       Impact factor: 5.460

5.  Cardiac magnetic resonance for the risk stratification of heart transplant recipients: ready for prime time?

Authors:  Nina P Hofmann; Hugo A Katus; Grigorios Korosoglou
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

6.  CMR-derived extracellular volume fraction (ECV) in asymptomatic heart transplant recipients: correlations with clinical features and myocardial edema.

Authors:  Yating Yuan; Jie Cai; Yue Cui; Jing Wang; Osamah Alwalid; Xuehua Shen; Yukun Cao; Yan Zou; Bo Liang
Journal:  Int J Cardiovasc Imaging       Date:  2018-07-28       Impact factor: 2.357

Review 7.  Cardiovascular magnetic resonance: applications in daily practice.

Authors:  Ronny S Jiji; Christopher M Kramer
Journal:  Cardiol Rev       Date:  2011 Sep-Oct       Impact factor: 2.644

8.  Magnetic resonance assessment of left ventricular diastolic dysfunction for detecting cardiac allograft vasculopathy in recipients of heart transplants.

Authors:  Haruhiko Machida; Shinichi Nunoda; Kiyotaka Okajima; Kazunobu Shitakura; Akihiko Sekikawa; Yutaka Kubo; Kuniaki Otsuka; Masami Hirata; Shinya Kojima; Eiko Ueno
Journal:  Int J Cardiovasc Imaging       Date:  2011-03-26       Impact factor: 2.357

Review 9.  Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review.

Authors:  Craig R Butler; Richard Thompson; Mark Haykowsky; Mustafa Toma; Ian Paterson
Journal:  J Cardiovasc Magn Reson       Date:  2009-03-12       Impact factor: 5.364

10.  The challenge to detect heart transplant rejection and transplant vasculopathy non-invasively - a pilot study.

Authors:  Engin Usta; Christof Burgstahler; Hermann Aebert; Stephen Schroeder; Uwe Helber; Andreas F Kopp; Gerhard Ziemer
Journal:  J Cardiothorac Surg       Date:  2009-08-16       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.